SR9009 has antitumoractivity in small cell lung cancer by targeting Reverb alpha through the suppression of autophagy gene Atg5 [5].Based on literature review, we have been taken Reverbα as a breast cancer target for docking analysis. Here, NR1D1 is linked to breast cancer.